Trials
Search / Trial NCT06433336

Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation

Launched by LANZHOU UNIVERSITY SECOND HOSPITAL · May 22, 2024

Apply for Trial

Trial Information

Current as of March 13, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • The inclusion criteria were age \>18 years and a diagnosis of AF by electrocardiogram during the preceding six months or on admission
  • Exclusion Criteria:
  • • No follow-up

Trial Officials

xiao wei xiaowei zhang, PHD

Principal Investigator

Lanzhou University Second Hospital

About Lanzhou University Second Hospital

Lanzhou University Second Hospital is a prominent clinical research institution affiliated with Lanzhou University, located in Gansu Province, China. Renowned for its commitment to advancing medical science and improving patient care, the hospital engages in a wide range of clinical trials across various therapeutic areas. With a focus on innovative research methodologies and adherence to ethical standards, Lanzhou University Second Hospital aims to contribute significantly to the global medical community by facilitating groundbreaking studies that enhance treatment options and health outcomes for patients. Its multidisciplinary team of experienced researchers and healthcare professionals collaborates closely with regulatory bodies to ensure the highest quality and integrity in all clinical trial endeavors.

Locations

Lanzhou, Gansu, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0